共 208 条
[1]
Nikfar S(2002)Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis Dig Dis Sci 47 1526-1529
[2]
Abdollahi M(2020)Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy Aliment Pharmacol Ther 51 410-420
[3]
Moretti ME(2015)The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors Int J Clin Pharm 37 709-716
[4]
Magee LA(2003)Switching omeprazole in Sweden and the United States Am J Ther 10 370-376
[5]
Koren G(2012)Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study Aliment Pharmacol Ther 35 1190-1198
[6]
Li CM(2015)Potential role of the intestinal microbiota in programming health and disease Nutr Rev 73 32-40
[7]
Zhernakova A(2014)Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome Front Immunol 5 595-385
[8]
Engstrand L(2015)Maternal microbiome and pregnancy outcomes that impact infant health: a review Adv Neonatal Care 15 377-499
[9]
Wijmenga C(2020)The pregnancy microbiome and preterm birth Semin Immunopathol 42 487-748
[10]
Brusselaers N(2020)The immune system and microbiome in pregnancy Best Pract Res Clin Gastroenterol 44–45 101671-757